Table 3.
Patterns of isolated lymph node relapse ovarian carcinoma
| Cases (n) | Proportion of cases (%) | |
|---|---|---|
| ILNR pattern | ||
| Single-site | 22 | 44.9 |
| Multiregional | ||
| 2 | 17 | 34.7 |
| 3 | 8 | 16.3 |
| 4 | 2 | 4.1 |
| ILNR sites | ||
| Para-aortic only | 16 | 32.7 |
| Pelvic only | 4 | 8.2 |
| Inguinal only | 2 | 4.1 |
| Pelvic & para-aortic | 6 | 12.2 |
| Supraclavicular and other sites | 6 | 12.2 |
| Pelvic, para-aortic, and other(s) | 6 | 12.2 |
| Other combinations | 9 | 18.4 |
ILNR, isolated lymph node relapse.
Hollis et al. Clinical and molecular characterization of ILNR ovarian carcinoma. Am J Obstet Gynecol 2019.